Corticosteroids in COVID-19

Phase 2

Recruiting

• Conditions: COVID-19 pneumonia.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20100228003449N31
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 119

Inclusion Criteria

Adult patients (18-85 years old)
With diagnose of COVID-19 according to laboratory, clinical or radiological findings
With indication for hospitalization

Exclusion Criteria

Contraindication of corticosteroids (uncontrolled diabetes mellitus, active bacteria, fungal or parasite infections, hypersensitivity reactions, close angle glaucoma, uncontrolled neuropsychiatric disorders, unstable cardiovascular disorders including acute myocardial infarction, acute thrombosis, uncontrolled hypertension, viral hepatitis, history of corticosteroids induced myopathy)
Pregnancy
Lactation
History of recent corticosteroids or other immunosuppressant drugs use

Study & Design

• Study Type: interventional
• Study Design: Not specified